# Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance

> **NCT03025841** · PHASE1 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 18 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Ceftaroline

## Key facts

- **NCT ID:** NCT03025841
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03025841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03025841, "Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03025841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*